News
The grey market premium (GMP) for Gem Aromatics IPO stands at +28, suggesting that its shares were trading at a premium of ...
Viking Therapeutics shares plunged 40% after trial data for its obesity pill, VK2735, revealed high dropout rates due to side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results